Corporate calendar for Coeptis Therapeutics Holdings, Inc. (COEP): upcoming earnings dates, dividend ex-dates and payment dates, stock splits, shareholder meetings and conference calls. Plan your positions around the key catalysts.
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology.
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|---|---|
| 2026-09-14 | ||
| 2026-09-14 | $0.10 | $672M |
| 2026-09-14 | $-0.00 | $3M |
| 2026-09-14 | ||
| 2026-09-14 | ||
| 2026-09-14 |
Stock Splits
| Date | Ratio |
|---|---|
| 2024-12-31 | 1:20 |
| 2020-08-06 | 1:200 |
Price
| Price | $10.99 |
| Market Cap | $39M |
| Exchange | NASDAQ |
| Country | US |
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Related companies: CUE · EQ · IPSC · KPTI · MDCX · NRXP · OSTX
Explore sector: Technology · Software - Services
More sections of COEP: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · News
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks